Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
Healive® was the only Chinese WHO-prequalified inactivated vaccine for the hepatitis A virus, which has been widely used in national immunization programs in China. Long-term follow-up studies are needed to estimate the persistence of vaccine-induced antibody levels and the necessity for booster vac...
Saved in:
Main Authors: | Xiaoli Wang (Author), Wenguo Xu (Author), Yuansheng Hu (Author), Hui Yao (Author), Li Xu (Author), Minhua Ma (Author), Ying Zhang (Author), Yalong Wang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
by: Yongji Wang, et al.
Published: (2020) -
Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children
by: Yan Qiu, et al.
Published: (2022) -
Review of long term immunogenicity and tolerability of live hepatitis A vaccine
by: Nitin Shah, et al.
Published: (2020) -
Persistent cloaca: A long-term follow-up study
by: Dinesh H Kittur, et al.
Published: (2017) -
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial
by: Yongliang Feng, et al.
Published: (2017)